HSBC Holdings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-145,800
Closed -$14.5M 3304
2019
Q3
$14.5M Sell
145,800
-100
-0.1% -$9.5K 0.03% 672
2019
Q2
$13.5M Sell
145,900
-225,500
-61% -$21.4M 0.03% 680
2019
Q1
$35M Sell
371,400
-298,700
-45% -$26.1M 0.06% 308
2018
Q4
$42.9M Buy
670,100
+33,400
+5% +$2.47M 0.08% 256
2018
Q3
$57M Buy
636,700
+215,100
+51% +$19M 0.09% 213
2018
Q2
$33.5M Sell
421,600
-142,500
-25% -$11.8M 0.06% 319
2018
Q1
$50.3M Buy
564,100
+523,600
+1,293% +$50.3M 0.07% 254
2017
Q4
$4.23M Sell
40,500
-433,500
-91% -$48.9M 0.01% 900
2017
Q3
$69.1M Buy
474,000
+68,400
+17% +$9.32M 0.11% 155
2017
Q2
$52.7M Buy
405,600
+50,100
+14% +$6.14M 0.1% 195
2017
Q1
$44.2M Sell
355,500
-139,100
-28% -$16.6M 0.09% 211
2016
Q4
$57.3M Buy
494,600
+191,400
+63% +$21.3M 0.13% 160
2016
Q3
$31.7M Buy
303,200
+31,600
+12% +$3.42M 0.08% 292
2016
Q2
$26.8M Buy
271,600
+123,300
+83% +$12.8M 0.07% 320
2016
Q1
$14.8M Sell
148,300
-84,500
-36% -$8.7M 0.04% 504
2015
Q4
$27.9M Buy
232,800
+169,900
+270% +$19.7M 0.07% 336
2015
Q3
$6.8M Buy
+62,900
New +$7.81M 0.02% 711
2015
Q2
Sell
-117,300
Closed -$13.5M 2408
2015
Q1
$13.5M Buy
117,300
+4,300
+4% +$514K 0.03% 564
2014
Q4
$12.6M Buy
113,000
+50,000
+79% +$5.27M 0.03% 592
2014
Q3
$5.97M Buy
+63,000
New +$5.69M 0.01% 811
2014
Q1
Sell
-86,000
Closed -$7.27M 1855
2013
Q4
$7.27M Buy
86,000
+40,000
+87% +$3.17M 0.02% 738
2013
Q3
$3.54M Buy
+46,000
New +$3.22M 0.01% 933

Other funds holding CELG

HSBC Holdings's CELG Position: Q4 2019 in Review

HSBC Holdings sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 666,283 shares — an estimated $66.2M sold.

HSBC Holdings first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $229M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HSBC Holdings reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HSBC Holdings sold 666,283 Celgene Corp shares in Q4 2019, an estimated $66.2M.
  • HSBC Holdings first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • HSBC Holdings's Celgene Corp position peaked at $229M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HSBC Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.